THE PHARMACOKINETICS OF DOXIFLURIDINE AND 5-FLUOROURACIL AFTER SINGLE INTRAVENOUS INFUSIONS OF DOXIFLURIDINE TO PATIENTS WITH COLORECTAL-CANCER

被引:11
作者
SCHAAF, LJ
DOBBS, BR
EDWARDS, IR
PERRIER, DG
机构
[1] UNIV OTAGO,SCH MED,DEPT PHARM,DUNEDIN,NEW ZEALAND
[2] UNIV OTAGO,SCH MED,MRC,TOXICOL RES UNIT,DUNEDIN,NEW ZEALAND
关键词
D O I
10.1007/BF01046699
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:439 / 443
页数:5
相关论文
共 20 条
[1]  
ABELE R, 1982, CANCER TREAT REP, V66, P1307
[2]  
ARMSTRONG RD, 1983, CANCER RES, V43, P2525
[3]  
ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[4]  
ARMSTRONG RD, 1981, CANCER RES, V41, P4891
[5]  
BENET LZ, 1984, PHARMACOKINETIC BASI, P1
[6]   TUMOR INHIBITORY EFFECTS OF A NEW FLUOROURACIL DERIVATIVE - 5'-DEOXY-5-FLUOROURIDINE [J].
BOLLAG, W ;
HARTMANN, HR .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) :427-432
[7]   NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].
COLLINS, JM ;
DEDRICK, RL ;
KING, FG ;
SPEYER, JL ;
MYERS, CE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246
[8]  
CONNOLLY KM, 1983, CANCER RES, V43, P2529
[9]  
DEBRUIJN EA, 1985, CANCER RES, V45, P5931
[10]   A formula to estimate the approximate surface area if height and weight be known [J].
Du Bois, D ;
Du Bois, EF .
ARCHIVES OF INTERNAL MEDICINE, 1916, 17 (06) :863-871